Clinical Trials Browser

Interventional × Breast Neoplasms × Drug Evaluation × Clear all

NCT05054751 2024-10-10

GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT02538471 2019-12-09

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer

Phase 2 Terminated

3 enrolled 11 charts

Breast Neoplasms

NCT03910712 2019-04-10

Pyrotinib

Phase 2 Unknown

Breast Diseases, Breast Neoplasms